PP-115 - Extended half-life product (rFVIIIFC) for treatment of children with hemophilia A: preliminary post-switch experience from a tertiary care center
- Resource Type
- Abstract
- Source
- In
Leukemia Research October 2019 85 Supplement 1:S81-S81 - Subject
- Language
- ISSN
- 0145-2126